Improving patient-centred care for rheumatoid arthritis.
作者信息
Bansback Nick, Shojania Kam, Lacaille Diane
机构信息
School of Population and Public Health (Bansback); Division of Rheumatology (Shojania, Lacaille), University of British Columbia; Centre for Health Evaluation and Outcome Sciences (Bansback, Shojania), St Paul's Hospital, Vancouver; Arthritis Research Canada (Bansback, Shojania, Lacaille), Richmond, BC
School of Population and Public Health (Bansback); Division of Rheumatology (Shojania, Lacaille), University of British Columbia; Centre for Health Evaluation and Outcome Sciences (Bansback, Shojania), St Paul's Hospital, Vancouver; Arthritis Research Canada (Bansback, Shojania, Lacaille), Richmond, BC.
出版信息
CMAJ. 2016 Oct 4;188(14):999-1000. doi: 10.1503/cmaj.160051. Epub 2016 Jun 27.
Abstract
摘要
相似文献
1
Improving patient-centred care for rheumatoid arthritis.
CMAJ. 2016 Oct 4;188(14):999-1000. doi: 10.1503/cmaj.160051. Epub 2016 Jun 27.
2
The combination of methotrexate, sulfasalazine and hydroxychloroquine is highly effective in rheumatoid arthritis.
Clin Exp Rheumatol. 1999 Jan-Feb;17(1):39-40.
3
Making rational treatment decisions in rheumatoid arthritis when methotrexate fails.
N Engl J Med. 2013 Jul 25;369(4):384-5. doi: 10.1056/NEJMe1306381. Epub 2013 Jun 11.
4
Conventional triple therapy as good as etanercept for uncontrolled rheumatoid arthritis.
BMJ. 2013 Jun 18;346:f3846. doi: 10.1136/bmj.f3846.
5
Treatment of rheumatoid arthritis.
N Engl J Med. 1996 Sep 12;335(11):821-2; author reply 822-3.
6
Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications.
N Engl J Med. 1996 May 16;334(20):1287-91. doi: 10.1056/NEJM199605163342002.
7
Therapies for active rheumatoid arthritis after methotrexate failure.
N Engl J Med. 2013 Jul 25;369(4):307-18. doi: 10.1056/NEJMoa1303006. Epub 2013 Jun 11.
8
Treatment of rheumatoid arthritis.
N Engl J Med. 1996 Sep 12;335(11):822; author reply 822-3.
9
Combination DMARD therapy with hydroxychloroquine, sulfasalazine, and methotrexate.
Clin Exp Rheumatol. 1999 Nov-Dec;17(6 Suppl 18):S53-8.
10
Rheumatoid arthritis. Triple therapy or etanercept after methotrexate failure in RA?
Nat Rev Rheumatol. 2013 Sep;9(9):510-2. doi: 10.1038/nrrheum.2013.118. Epub 2013 Jul 30.
引用本文的文献
1
Rheumatoid arthritis: a comprehensive overview of genetic markers, emerging therapies, and personalized medicine.
Ann Med Surg (Lond). 2025 Jan 7;87(2):696-710. doi: 10.1097/MS9.0000000000002890. eCollection 2025 Feb.
本文引用的文献
1
When Patients Write the Guidelines: Patient Panel Recommendations for the Treatment of Rheumatoid Arthritis.
Arthritis Care Res (Hoboken). 2016 Jan;68(1):26-35. doi: 10.1002/acr.22758. Epub 2015 Nov 6.
2
Therapies for active rheumatoid arthritis after methotrexate failure.
N Engl J Med. 2013 Jul 25;369(4):307-18. doi: 10.1056/NEJMoa1303006. Epub 2013 Jun 11.
3
A retrospective cohort study: 10-year trend of disease-modifying antirheumatic drugs and biological agents use in patients with rheumatoid arthritis at Veteran Affairs Medical Centers.
BMJ Open. 2013 Apr 5;3(4). doi: 10.1136/bmjopen-2012-002468. Print 2013.
4
Stop the silent misdiagnosis: patients' preferences matter.
BMJ. 2012 Nov 8;345:e6572. doi: 10.1136/bmj.e6572.
5
A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: the treatment of Early Aggressive Rheumatoid Arthritis Trial.
Arthritis Rheum. 2012 Sep;64(9):2824-35. doi: 10.1002/art.34498.
6
Conventional combination treatment versus biological treatment in methotrexate-refractory early rheumatoid arthritis: 2 year follow-up of the randomised, non-blinded, parallel-group Swefot trial.
Lancet. 2012 May 5;379(9827):1712-20. doi: 10.1016/S0140-6736(12)60027-0. Epub 2012 Mar 29.
7
Shared decision making--pinnacle of patient-centered care.
N Engl J Med. 2012 Mar 1;366(9):780-1. doi: 10.1056/NEJMp1109283.
8
Canadian Rheumatology Association recommendations for pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs.
J Rheumatol. 2012 Aug;39(8):1559-82. doi: 10.3899/jrheum.110207. Epub 2011 Sep 15.
9
A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview.
CMAJ. 2009 Nov 24;181(11):787-96. doi: 10.1503/cmaj.091391. Epub 2009 Nov 2.
10
Discordant perspectives of rheumatologists and patients on COBRA combination therapy in rheumatoid arthritis.
Rheumatology (Oxford). 2008 Oct;47(10):1571-6. doi: 10.1093/rheumatology/ken323. Epub 2008 Aug 18.
Zotero 插件